IMC Chicago’s Jazz Pharmaceuticals JAZZ Stock Holding History

IMC Chicago’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$705K	Buy	+3,045	New	+$752K	﹤0.01%	4306

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Zurich Cantonal Bank Zurich, Switzerland $53.5B AUM 32.01% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return

IMC Chicago's JAZZ Position: Q3 2026 in Review

IMC Chicago opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2026: 3,045 shares worth $705K. The stake represents ﹤0.01% of the portfolio and ranks #4306 among its holdings.

394 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

IMC Chicago held 3,045 shares of Jazz Pharmaceuticals worth $705K as of Q3 2026.
Jazz Pharmaceuticals was a new IMC Chicago position in Q3 2026.
Jazz Pharmaceuticals made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #4306 holding.
394 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.